Amendments to Implementing Decision 2011/807/EU
Article 9
Implementing Decision 2011/807/EU is amended as follows: (1) in Article 1(2), point (c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 3 600 000 for Spain; (ii) EUR 2 300 000 for Italy; (iii) EUR 1 050 000 for Portugal; (iv) EUR 1 050 000 for the United Kingdom.’; (2) in Article 2(2), point (a) is replaced by the following: ‘(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests: (i) EUR 0,5 per domestic animal sampled for gamma interferon test and suspected positive in the slaughterhouse; (ii) EUR 1,5 per tuberculin test; (iii) EUR 5 per gamma interferon test; (iv) EUR 20 per bacteriological test.’; (3) in Article 2(2), point (c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 19 000 000 for Ireland; (ii) EUR 14 000 000 for Spain; (iii) EUR 4 000 000 for Italy; (iv) EUR 2 650 000 for Portugal; (v) EUR 31 000 000 for the United Kingdom.’; (4) in Article 3(2), point (c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 800 000 for Greece; (ii) EUR 8 900 000 for Spain; (iii) EUR 3 700 000 for Italy; (iv) EUR 180 000 for Cyprus; (v) EUR 1 800 000 for Portugal.’; (5) in Article 4(2), point (c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 150 000 for Belgium; (ii) EUR 15 000 for Bulgaria; (iii) EUR 40 000 for the Czech Republic; (iv) EUR 80 000 for Germany; (v) EUR 10 000 for Estonia; (vi) EUR 25 000 for Ireland; (vii) EUR 60 000 for Greece; (viii) EUR 700 000 for Spain; (ix) EUR 1 200 000 for France; (x) EUR 650 000 for Italy; (xi) EUR 20 000 for Latvia; (xii) EUR 10 000 for Lithuania; (xiii) EUR 10 000 for Luxembourg; (xiv) EUR 30 000 for Hungary; (xv) EUR 10 000 for Malta; (xvi) EUR 20 000 for the Netherlands; (xvii) EUR 10 000 for Austria; (xviii) EUR 50 000 for Poland; (xix) EUR 300 000 for Portugal; (xx) EUR 150 000 for Romania; (xxi) EUR 40 000 for Slovenia; (xxii) EUR 50 000 for Slovakia; (xxiii) EUR 10 000 for Finland; (xxiv) EUR 10 000 for Sweden.’; (6) in Article 5(3), point (c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 1 200 000 for Belgium; (ii) EUR 20 000 for Bulgaria; (iii) EUR 1 200 000 for the Czech Republic; (iv) EUR 250 000 for Denmark; (v) EUR 900 000 for Germany; (vi) EUR 30 000 for Estonia; (vii) EUR 200 000 for Ireland; (viii) EUR 1 000 000 for Greece; (ix) EUR 1 100 000 for Spain; (x) EUR 1 550 000 for France; (xi) EUR 1 200 000 for Italy; (xii) EUR 100 000 for Cyprus; (xiii) EUR 350 000 for Latvia; (xiv) EUR 10 000 for Luxembourg; (xv) EUR 2 000 000 for Hungary; (xvi) EUR 150 000 for Malta; (xvii) EUR 2 700 000 for the Netherlands; (xviii) EUR 1 100 000 for Austria; (xix) EUR 500 000 for Poland; (xx) EUR 50 000 for Portugal; (xxi) EUR 350 000 for Romania; (xxii) EUR 70 000 for Slovenia; (xxiii) EUR 600 000 for Slovakia; (xxiv) EUR 75 000 for the United Kingdom.’; (7) Article 6 is amended as follows: (a) paragraph 2 is amended as follows: (i) the introductory phrase is replaced by the following: ‘The financial contribution by the Union for the programmes submitted by the Member States referred to in point (a) of paragraph 1:’; (ii) point (b) is replaced by the following: ‘(b) shall not exceed the following: (i) EUR 210 000 for Bulgaria; (ii) EUR 1 200 000 for Germany; (iii) EUR 200 000 for France; (iv) EUR 10 000 for Luxembourg; (v) EUR 340 000 for Hungary; (vi) EUR 900 000 for Romania; (vii) EUR 30 000 for Slovenia; (viii) EUR 500 000 for Slovakia.’; (b) the following paragraph 3 is added: ‘3. The financial contribution by the Union for the programme submitted by Italy as referred to in point (b) of paragraph 1: (a) shall be at the rate of 50 % of the costs to be incurred by Italy for: (i) carrying out laboratory tests with a maximum not exceeding: — EUR 2 per ELISA test — EUR 10 per PCR test and — EUR 10 per virological test; (ii) the salaries of contractual staff specially recruited for the implementation of the measures of that programme, other than to carry out laboratory tests; (b) shall not exceed EUR 850 000.’; (8) in Article 8(2), point (c) is amended as follows: (a) point (ix) is replaced by the following: ‘(ix) EUR 140 000 for Spain;’; (b) point (xi) is replaced by the following: ‘(xi) EUR 1 000 000 for Italy;’; (c) point (xxii) is replaced by the following: ‘(xxii) EUR 350 000 for Romania;’; (d) point (xxvii) is replaced by the following: ‘(xxvii) EUR 110 000 for the United Kingdom.’; (9) in Article 9(2), point (c) is amended as follows: (a) point (ii) is replaced by the following: ‘(ii) EUR 340 000 for Bulgaria;’; (b) point (iv) is replaced by the following: ‘(iv) EUR 750 000 for Denmark;’; (c) point (v) is replaced by the following: ‘(v) EUR 6 300 000 for Germany;’; (d) point (viii) is replaced by the following: ‘(viii) EUR 1 800 000 for Greece;’; (e) point (xi) is replaced by the following: ‘(xi) EUR 4 800 000 for Italy;’; (f) point (xvi) is replaced by the following: ‘(xvi) EUR 1 300 000 for Hungary;’; (g) point (xviii) is replaced by the following: ‘(xviii) EUR 2 200 000 for the Netherlands;’; (h) point (xxi) is replaced by the following: ‘(xxi) EUR 1 100 000 for Portugal’; (i) point (xxvii) is replaced by the following: ‘(xxvii) EUR 5 100 000 for the United Kingdom.’; (10) in Article 10(2), point (c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 1 650 000 for Bulgaria; (ii) EUR 620 000 for Estonia; (iii) EUR 1 400 000 for Hungary; (iv) EUR 9 850 000 for Poland; (v) EUR 2 200 000 for Romania; (vi) EUR 400 000 for Slovakia.’; (11) in Article 11(5), point (c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 1 200 000 for Italy; (ii) EUR 1 700 000 for Latvia; (iii) EUR 2 950 000 for Lithuania; (iv) EUR 190 000 for Austria; (v) EUR 840 000 for Slovenia; (vi) EUR 360 000 for Finland.’